性器ヘルペス治療の世界市場2021年ー2027年:薬剤種類別(アシクロビル、バラシクロビル、ファムシクロビル)、流通チャネル別、投与経路別、疾患別、地域別

【英語タイトル】Global Genital Herpes Treatment Market Size study, by Drug Type (Acyclovir, Valacyclovir, Famciclovir) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) Route of Administration (Oral, Topical, Injectable) Indication (HSV-1, HSV-2) and Regional Forecasts 2021-2027

Bizwit Research & Consultingが出版した調査資料(BZW21JL174)・商品コード:BZW21JL174
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2021年7月17日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2020年におよそXX億ドルであった性器ヘルペス治療の世界市場規模が、2021年から2027年の間にXX%以上の健全な成長率で成長すると予想しています。本調査レポートでは、世界の性器ヘルペス治療市場について調査・分析を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、薬剤種類別(アシクロビル、バラシクロビル、ファムシクロビル)分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局、ドラッグストア)分析、投与経路別(経口、局所、注射)分析、疾患別(HSV-1、HSV-2)分析、地域別分析、競争状況、調査プロセスなどの項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・性器ヘルペス治療の世界市場規模:薬剤種類別(アシクロビル、バラシクロビル、ファムシクロビル)
・性器ヘルペス治療の世界市場規模:流通チャネル別(病院薬局、小売薬局、オンライン薬局、ドラッグストア)
・性器ヘルペス治療の世界市場規模:投与経路別(経口、局所、注射)
・性器ヘルペス治療の世界市場規模:疾患別(HSV-1、HSV-2)
・性器ヘルペス治療の世界市場規模:地域別
・競争状況
・調査プロセス

Global Genital Herpes Treatment Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Herpes simplex virus (HSV) causes genital herpes, a sexually transmitted illness that is spread by infected people’s sperm, saliva, and vaginal fluids. Herpes simplex viruses come in two varieties: HSV-1 and HSV-2. Blisters on the genital organs, blisters in the mouth, lips, and other regions, itching or tingling in the infected areas, pelvic discomfort, vaginal discharge, and other symptoms are all frequent genital herpes symptoms. Therapy options for genital herpes include medication, episodic treatment, and suppressive treatment, among others. Commercially available antiviral medications for the treatment of genital herpes include Acyclovir, Famciclovir, and Valacyclovir. Over the projected period, the rising frequency of sexually transmitted diseases, particularly genital herpes, is likely to drive demand for genital herpes therapy. According to the Centers for Disease Control and Prevention, genital herpes affects roughly 50 million people in the United States. During the projected period, factors such as rising genital herpes diagnosis rates in emerging nations and expanding clinical trials of genital herpes vaccines have further fueled the expansion of the genital herpes market. Sanofi Pasteur, for example, is working on a herpes vaccine called HSV529 in partnership with the National Institute of Allergy and Infectious Diseases. The vaccine is categorised as a replication-defective virus, which means it has all of the HSV virus’s components minus two key proteins required in viral DNA replication, UL5 and UL29. GlaxoSmithKline plc started phase 1 human clinical trials for their investigational HSV-2 vaccine in March 2021, with the goal of determining the reactogenicity, safety, and immunogenicity of four different dosage levels of the vaccine in healthy adults aged 18 to 40. Furthermore, rising government support for the development of novel therapeutics for the treatment of genital herpes is expected to drive market expansion during the forecast period. Furthermore, in developed countries, accurate diagnostic techniques such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, and real-time PCR assays are widely utilized to identify STIs. These tests are effective for diagnosing asymptomatic infections, which will boost demand for genital herpes therapy and propel the industry forward. Inadequate reimbursement and a poor treatment seeking rate for genital herpes, on the other hand, will stifle market growth between 2021 and 2027. Although, throughout the forecast period, increasing demand for genital herpes treatment medicines by homosexuals presents a profitable opportunity for the market.

The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Genital Herpes Treatment market. Because of the significant growth of herpes cases in the region, North America is the world’s top region in terms of market share. According to the Centers for Disease Control and Prevention, genital herpes affects one out of every six persons in the United States between the ages of 14 and 49. Whereas, Asia-Pacific is expected to expand at the fastest pace during the forecast period, as the region’s quickly growing population, as well as increased awareness and diagnosis, would provide attractive potential opportunities for the Genital Herpes Treatment market.

Major market player included in this report are:
Teva Pharmaceutical Industries Ltd
Abbott Laboratories
Sun Pharmaceuticals Industries Ltd.
Mylan N.V.
Pfizer Inc.
GlaxoSmithKline plc
Dr. Reddy’s Laboratories ltd.
Novartis AG
Valeant Pharmaceuticals International Inc.
Genocea Biosciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:
Acyclovir
Valacyclovir
Famciclovir

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

By Route of Administration:
Oral
Topical
Injectable

By Indication:
HSV-1
HSV-2

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Genital Herpes Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Genital Herpes Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Genital Herpes Treatment Market, by Drug Type, 2019-2027 (USD Billion)
1.2.3. Genital Herpes Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
1.2.4. Genital Herpes Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.5. Genital Herpes Treatment Market, by Indication, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Genital Herpes Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Genital Herpes Treatment Market Dynamics
3.1. Genital Herpes Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising frequency of sexually transmitted diseases
3.1.1.2. Expanding clinical trials of genital herpes vaccines
3.1.2. Market Challenges
3.1.2.1. Inadequate reimbursement and a poor treatment seeking rate for genital herpes
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for genital herpes treatment medicines by homosexuals
Chapter 4. Global Genital Herpes Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Genital Herpes Treatment Market, by Drug Type
5.1. Market Snapshot
5.2. Global Genital Herpes Treatment Market by Drug Type, Performance – Potential Analysis
5.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
5.4. Genital Herpes Treatment Market, Sub Segment Analysis
5.4.1. Acyclovir
5.4.2. Valacyclovir
5.4.3. Famciclovir
Chapter 6. Global Genital Herpes Treatment Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Genital Herpes Treatment Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
6.4. Genital Herpes Treatment Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Drug Stores
Chapter 7. Global Genital Herpes Treatment Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Genital Herpes Treatment Market by Route of Administration, Performance – Potential Analysis
7.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
7.4. Genital Herpes Treatment Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Topical
7.4.3. Injectable
Chapter 8. Global Genital Herpes Treatment Market, by Indication
8.1. Market Snapshot
8.2. Global Genital Herpes Treatment Market by Indication, Performance – Potential Analysis
8.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
8.4. Genital Herpes Treatment Market, Sub Segment Analysis
8.4.1. HSV-1
8.4.2. HSV-2
Chapter 9. Global Genital Herpes Treatment Market, Regional Analysis
9.1. Genital Herpes Treatment Market, Regional Market Snapshot
9.2. North America Genital Herpes Treatment Market
9.2.1. U.S. Genital Herpes Treatment Market
9.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2027
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2027
9.2.1.4. Indication breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Genital Herpes Treatment Market
9.3. Europe Genital Herpes Treatment Market Snapshot
9.3.1. U.K. Genital Herpes Treatment Market
9.3.2. Germany Genital Herpes Treatment Market
9.3.3. France Genital Herpes Treatment Market
9.3.4. Spain Genital Herpes Treatment Market
9.3.5. Italy Genital Herpes Treatment Market
9.3.6. Rest of Europe Genital Herpes Treatment Market
9.4. Asia-Pacific Genital Herpes Treatment Market Snapshot
9.4.1. China Genital Herpes Treatment Market
9.4.2. India Genital Herpes Treatment Market
9.4.3. Japan Genital Herpes Treatment Market
9.4.4. Australia Genital Herpes Treatment Market
9.4.5. South Korea Genital Herpes Treatment Market
9.4.6. Rest of Asia Pacific Genital Herpes Treatment Market
9.5. Latin America Genital Herpes Treatment Market Snapshot
9.5.1. Brazil Genital Herpes Treatment Market
9.5.2. Mexico Genital Herpes Treatment Market
9.6. Rest of The World Genital Herpes Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Teva Pharmaceutical Industries Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Sun Pharmaceuticals Industries Ltd.
10.2.4. Mylan N.V.
10.2.5. Pfizer Inc.
10.2.6. GlaxoSmithKline plc
10.2.7. Dr. Reddy’s Laboratories ltd.
10.2.8. Novartis AG
10.2.9. Valeant Pharmaceuticals International Inc.
10.2.10. Genocea Biosciences
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Genital Herpes Treatment market, report scope
TABLE 2. Global Genital Herpes Treatment market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Genital Herpes Treatment market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
TABLE 4. Global Genital Herpes Treatment market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
TABLE 5. Global Genital Herpes Treatment market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
TABLE 6. Global Genital Herpes Treatment market estimates & forecasts by Indication 2018-2027 (USD Billion)
TABLE 7. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. U.S. Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. U.S. Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 20. Canada Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Canada Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. Canada Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. UK Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. UK Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. UK Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Germany Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Germany Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Germany Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. RoE Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. RoE Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. RoE Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. China Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. China Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. China Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. India Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. India Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. India Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Japan Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Japan Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Japan Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. RoAPAC Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. RoAPAC Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. RoAPAC Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. Brazil Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. Brazil Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Brazil Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. Mexico Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. Mexico Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. Mexico Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. RoLA Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. RoLA Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. RoLA Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Row Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Row Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Row Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Genital Herpes Treatment market
TABLE 57. List of primary sources, used in the study of global Genital Herpes Treatment market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered


List of figures
FIG 1. Global Genital Herpes Treatment market, research methodology
FIG 2. Global Genital Herpes Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Genital Herpes Treatment market, key trends 2020
FIG 5. Global Genital Herpes Treatment market, growth prospects 2021-2027
FIG 6. Global Genital Herpes Treatment market, porters 5 force model
FIG 7. Global Genital Herpes Treatment market, pest analysis
FIG 8. Global Genital Herpes Treatment market, value chain analysis
FIG 9. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Genital Herpes Treatment market, regional snapshot 2018 & 2027
FIG 15. North America Genital Herpes Treatment market 2018 & 2027 (USD Billion)
FIG 16. Europe Genital Herpes Treatment market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Genital Herpes Treatment market 2018 & 2027 (USD Billion)
FIG 18. Latin America Genital Herpes Treatment market 2018 & 2027 (USD Billion)
FIG 19. Global Genital Herpes Treatment market, company market share analysis (2020)


★調査レポート[性器ヘルペス治療の世界市場2021年ー2027年:薬剤種類別(アシクロビル、バラシクロビル、ファムシクロビル)、流通チャネル別、投与経路別、疾患別、地域別] (コード:BZW21JL174)販売に関する免責事項を必ずご確認ください。
★調査レポート[性器ヘルペス治療の世界市場2021年ー2027年:薬剤種類別(アシクロビル、バラシクロビル、ファムシクロビル)、流通チャネル別、投与経路別、疾患別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆